Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Charmacy Pharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	786	1,058	1,400	744	603	588
Market Cap Growth	-19.11%	-24.38%	88.10%	23.48%	2.57%	-26.88%
Enterprise Value	1,536	1,681	1,659	1,548	1,675	1,021
Last Close Price	7.28	9.18	11.85	5.92	4.79	4.48
PE Ratio	14.86	18.67	24.75	7.28	21.21	12.20
Forward PE	-	13.45	13.45	13.45	13.45	13.45
PS Ratio	0.17	0.22	0.29	0.16	0.13	0.12
PB Ratio	1.21	1.61	2.13	1.11	0.97	0.98
P/TBV Ratio	1.39	1.84	2.47	1.30	1.38	1.44
P/FCF Ratio	2.91	11.01	-	18.56	-	6.26
P/OCF Ratio	2.80	9.38	-	14.94	-	3.77
EV/Sales Ratio	0.33	0.36	0.34	0.33	0.36	0.22
EV/EBITDA Ratio	8.74	10.15	11.59	11.32	13.18	7.83
EV/EBIT Ratio	10.70	11.69	13.91	14.65	18.33	9.76
EV/FCF Ratio	5.68	17.50	-	38.62	-	10.87
Debt / Equity Ratio	2.04	2.28	2.30	1.99	2.63	2.50
Debt / EBITDA Ratio	7.52	8.54	10.20	9.55	12.47	11.14
Debt / FCF Ratio	4.89	15.61	-	33.43	-	15.86
Asset Turnover	1.25	1.32	1.44	1.48	1.36	1.51
Inventory Turnover	5.17	5.75	6.04	7.13	6.51	6.83
Quick Ratio	0.64	0.66	0.63	0.66	0.66	0.65
Current Ratio	1.09	1.09	1.07	1.09	1.04	1.04
Return on Equity (ROE)	8.15%	8.76%	8.61%	16.46%	4.60%	8.22%
Return on Assets (ROA)	2.42%	2.52%	2.21%	2.08%	1.67%	2.08%
Return on Invested Capital (ROIC)	7.64%	7.27%	6.33%	5.62%	4.46%	5.86%
Return on Capital Employed (ROCE)	19.70%	20.20%	17.20%	15.30%	12.30%	13.80%
Earnings Yield	6.73%	5.36%	4.04%	13.74%	4.72%	8.20%
FCF Yield	34.39%	9.08%	-10.81%	5.39%	-9.08%	15.99%
Dividend Yield	6.72%	5.22%	2.79%	8.60%	-	5.30%
Payout Ratio	135.85%	120.49%	147.05%	31.44%	226.73%	139.34%
Buyback Yield / Dilution	-0.01%	0.01%	-0.00%	-0.01%	0.01%	-0.01%
Total Shareholder Return	6.71%	5.23%	2.79%	8.59%	0.01%	5.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.